摘要
性是影响药理反应的几个因素之一,虽然对药代动力学和药效学的研究影响显着,但不完善,并且包含许多方法问题。 在这次审查中,评估了药物动力学中性别差异的现状以及对药物基因组学的一些暗示。 此外,考虑到通过生物标志物监测的许多药理学反应,已经报道了性别对某些生物标志物的影响。 最后,我们报告了药物动力学中的性别差异,特别是分析了阿片类药物及其在怀孕,劳动和哺乳期间的使用效果。 总之,为精确的基于性别的方法,似乎有必要对于在男性和女性中进行更多循证治疗。
关键词: 性别差异,药代动力学,药效学,生物标志物,阿片样物质,怀孕。
Current Medicinal Chemistry
Title:Sex Impact on Biomarkers, Pharmacokinetics and Pharmacodynamics
Volume: 24 Issue: 24
关键词: 性别差异,药代动力学,药效学,生物标志物,阿片样物质,怀孕。
摘要: Sex is one of several factors influencing pharmacological responses, but research on its effects on pharmacokinetics and pharmacodynamics, although emerging remarkably, remains poor and contains many methodological issues. In this review, the current state of knowledge about sex differences in pharmacokinetics and some hints to pharmacogenomics were evaluated. Moreover, considering that many pharmacological responses are monitored through biomarkers, the influence of sex on some biomarkers has been reported. Finally, we report sex differences in pharmacodynamics, particularly analysing opioids and their use during pregnancy, labor and breastfeeding. In conclusion, a more precise sex- and genderbased approach appears necessary to achieve more evidence-based therapy in men and women.
Export Options
About this article
Cite this article as:
Sex Impact on Biomarkers, Pharmacokinetics and Pharmacodynamics, Current Medicinal Chemistry 2017; 24 (24) . https://dx.doi.org/10.2174/0929867323666161003124616
DOI https://dx.doi.org/10.2174/0929867323666161003124616 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vaccination in Pregnancy
Current Pharmaceutical Biotechnology Ion Transport Across the Gallbladder Epithelium
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Usefulness of Real-Time PCR for the Diagnosis of Sepsis in ICU-Acquired Infections
Infectious Disorders - Drug Targets Early Aged T-Cells in Immune-Mediated Diseases
Current Immunology Reviews (Discontinued) COVID-19, Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Inhibition: Implications for Practice
Current Hypertension Reviews Patent Selections
Recent Patents on Biotechnology Somatic Genome Variations in Health and Disease
Current Genomics Chemical and Genetic Engineering Strategies to Improve the Potency of Pharmaceutical Proteins and Enzymes
Current Medicinal Chemistry Cubilin, the Intrinsic Factor-Vitamin B12 Receptor in Development and Disease
Current Medicinal Chemistry ETS Proteins and MMPs: Partners in Invasion and Metastasis
Current Drug Targets High Throughput Screening for Bioactive Components from Traditional Chinese Medicine
Combinatorial Chemistry & High Throughput Screening ACE2 as a Key Target for Treatment of COVID-19 Related Cardiovascular Diseases: Current Progress and Prospect
Current Drug Targets Telomerase Therapeutics for Degenerative Diseases
Current Molecular Medicine Delivering RNA Interference to the Mammalian Brain
Current Gene Therapy Statistical Optimization of Pharmacogenomics Association Studies: Key Considerations from Study Design to Analysis
Current Pharmacogenomics and Personalized Medicine The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly
Current Drug Safety Biological Rationales and Clinical Applications of Temperature Controlled Hyperthermia - Implications for Multimodal Cancer Treatments
Current Medicinal Chemistry Purinergic (P2) Receptor Control of Lower Genitourinary Tract Function and New Avenues for Drug Action: An Overview
Current Pharmaceutical Design Better Antiretroviral Central Nervous System Penetration is Not Associated with Reduced Chronic Pain in People Living with Human Immunodeficiency Virus
Anti-Infective Agents Efficacy and Cardiovascular Safety of Thiazolidinediones
Current Drug Safety